PLx Pharma Inc.

NASDAQ:PLXP   3:59:59 PM EDT
13.32
+0.06 (+0.45%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)365.32M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.1 Million
Adjusted EPS-$0.46
See more estimates
10-Day MA$14.53
50-Day MA$17.38
200-Day MA$12.73
See more pivots

PLx Pharma Inc. Stock, NASDAQ:PLXP

9 Fishers Lane, Suite E, Sparta, New Jersey 07871
United States of America
Phone: +1.973.409.6541
Number of Employees: 11

Description

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. It offers PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Sparta, NJ.